24 studies found for:    DPYD
Show Display Options
Rank Status Study
1 Active, not recruiting Association of Dihydropyrimidine Dehydrogenase (DPYD) Variants With Toxicity Related to Capecitabine
Condition: Breast Cancer
Intervention: Procedure: Phlebotomy
2 Completed Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines
Condition: Neoplasms
Intervention: Drug: Capecitabine, 5-fluorouracil
3 Recruiting Pharmacology-driven Dosing of Fluoropyrimidines in Cancer Patients
Condition: Colorectal Cancer
Interventions: Other: 5FU and capecitabine (Xeloda®) dosing based on DPYD genotype;   Other: Therapeutic drug monitoring of 5FU
4 Completed A Study of ADH300004 in Surgically Resected Primary or Metastatic Colorectal Cancer and Liver Biopsy, or Planned Hepatic Resection
Condition: Neoplasms
Intervention: Drug: ADH300004
5 Recruiting Study of DPD for Predicting Efficacy and Safety to S-1 Plus Oxaliplatin in Gastrointestinal Cancer
Condition: Gastrointestinal Cancer
Intervention: Drug: S-1 plus oxaliplatin
6 Unknown  Pre-therapeutic Identification of Dihydropyrimidine Dehydrogenase Gene (DPD) Deficiency for Predicting Toxicity to Fluoropyrimidines
Conditions: Colorectal Cancer;   Intravenous 5 Fluorouracile
Intervention: Genetic: Blood sample for phenotypic and pharmacogenetic analysis.
7 Suspended A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors
Condition: Neoplasms
Intervention: Drug: ADH300004
8 Terminated A Study of ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Drug: ADH300004
9 Completed Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: eniluracil;   Procedure: conventional surgery
10 Unknown  Predicting Response to Capecitabine in Women With Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: capecitabine;   Other: laboratory biomarker analysis;   Other: pharmacological study
11 Completed A Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of S-1 on Advanced Solid Tumors
Condition: Tumors
Interventions: Drug: S-1;   Drug: FT
12 Completed A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors
Conditions: Lymphoma;   Neoplasms
Interventions: Drug: 5-Fluorouracil;   Drug: Ethynyluracil;   Drug: Leucovorin
13 Recruiting Study Of Pre-Operative Or Peri-Operative Docetaxel, Oxaliplatin, Capecitabine (Dox)Regimen In Patients With Locally Advanced Resectable Gastric Cancer
Condition: Gastric Cancer
Interventions: Other: DOX 4 cycles - Surgery;   Other: DOX  2 cycles - Surgery - DOX  2 cycles
14 Active, not recruiting Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer
Conditions: Colorectal Cancer;   Metastatic Cancer
Interventions: Drug: FOLFOX regimen;   Drug: dexamethasone;   Drug: floxuridine;   Drug: fluorouracil;   Drug: leucovorin calcium;   Drug: oxaliplatin;   Procedure: adjuvant therapy;   Procedure: conventional surgery
15 Unknown  Study of S1 Efficacy and Toxicity as Second-line Treatment on Inoperable or Advanced Gastric Cancers
Condition: Gastric Cancer
Intervention:
16 Active, not recruiting Study of S-1 as Second Line Treatment on Advanced Pancreatic Cancers
Condition: Pancreatic Cancer
Interventions: Drug: S-1;   Drug: S-1 plus Leucovorin
17 Unknown  Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer
Conditions: Gastric Cancer;   Esophageal Cancer;   Pancreatic Cancer;   Colon Cancer
Intervention: Drug: S-1
18 Completed Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: capecitabine;   Drug: docetaxel
19 Completed Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: Capecitabine;   Drug: Oxaliplatin
20 Completed Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat Cancers
Condition: Metastatic Breast Cancer
Interventions: Drug: Capecitabine;   Drug: Docetaxel

   Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results    Last Page
Indicates status has not been verified in more than two years